← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 31, 2004Last known activity
May 5, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 10 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Recent trials (14)
- NCT06740305CollaboratorPhase 1May 5, 2025
- NCT06214468CollaboratorPhase 1Jan 15, 2024
- NCT06133530CollaboratorN/ASep 24, 2023
- NCT06467825Lead sponsorN/AAug 9, 2022
- NCT05366933Lead sponsorPhase 1Aug 1, 2022
- NCT06467812Lead sponsorN/AApr 1, 2022
- NCT06467812OfficialN/AApr 1, 2022
- NCT05886660Overall official - principal investigatorPhase 2Jan 21, 2022
- NCT05886660CollaboratorPhase 2Jan 21, 2022
- NCT05852730CollaboratorPhase 2Aug 10, 2021
- NCT05852730Overall official - principal investigatorPhase 2Aug 10, 2021
- NCT03526575Overall official - principal investigatorPhase 4Jan 10, 2011
- NCT03526575Lead sponsorPhase 4Jan 10, 2011
- NCT00664053Lead sponsorPhase 4Oct 31, 2004
Details
- Last known activity
- May 5, 2025